InsidersTradesSigma
Follow the 디알텍 share price and the full directors' dealings record of the company, a publicly traded company based in South Korea. Shares are quoted on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, 디알텍 has logged 41 insider filings. Market capitalisation: €67bn. The latest transaction was filed on 23 June 2026 (Other). Among the most active insiders: 윤정기. The full history is free.
41
Insider Decl.
n/a
Thresholds
€5,735
16 ops.
Buy Volume
n/a
8 ops.
Sell Volume
22Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 27,390 of 28,892 companies
16.1
score / 100
Value7
Quality25
FCF yld-34%
Earn yld-30%
EV/EBITDA·
ROE-16%
Gross mgn36%
Net mgn-21%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 23 June 2026
Declarations41 total
5,591,277 sharesKRXDART:20240528000432
25 of 41 declarations
About 디알텍
디알텍 is a company operating in the healthcare and pharmaceutical sector, listed on the XKRX market. It specializes in developing innovative solutions for the medical field.